27.04.2021 19:40:00
|
ANI Pharmaceuticals, Inc. -- Moody's assigns first-time B2 CFR to ANI Pharmaceuticals; outlook stable
Rating Action: Moody's assigns first-time B2 CFR to ANI Pharmaceuticals; outlook stableVollständigen Artikel bei Moodys lesen